Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: our current price supports earnings of 2.7 million per 1/4

our current price supports earnings of 2.7 million per 1/4

posted on Oct 05, 2009 12:46PM

... that is with a 12 pe.... (I subtracted our per share net assets(5 cents a share)..CNBC recomdended way of figureing out PE's).... WOW we are undervalued!!!! that is if earnings do not grow!!!!!

Share
New Message
Please login to post a reply